...
首页> 外文期刊>Journal of Tropical Medicine >Utility of the Rose Bengal Test as a Point-of-Care Test for Human Brucellosis in Endemic African Settings: A Systematic Review
【24h】

Utility of the Rose Bengal Test as a Point-of-Care Test for Human Brucellosis in Endemic African Settings: A Systematic Review

机译:玫瑰孟加拉的效用作为地方非洲环境中人体布鲁氏菌素的护理点测试:系统审查

获取原文
           

摘要

In endemic African areas, such as Tanzania, Brucella spp. cause human febrile illnesses, which often go unrecognized and misdiagnosed, resulting in delayed diagnosis, underdiagnosis, and underreporting. Although rapid and affordable point-of-care tests, such as the Rose Bengal test (RBT), are available, acceptance and adoption of these tests at the national level are hindered by a lack of local diagnostic performance data. To address this need, evidence on the diagnostic performance of RBT as a human brucellosis point-of-care test was reviewed. The review was initially focused on studies conducted in Tanzania but was later extended to worldwide because few relevant studies from Tanzania were identified. Databases including Web of Science, Embase, MEDLINE, and World Health Organization Global Index Medicus were searched for studies assessing the diagnostic performance of RBT (sensitivity and specificity) for detection of human brucellosis, in comparison to the reference standard culture. Sixteen eligible studies were identified and reviewed following screening. The diagnostic sensitivity (DSe) and specificity (DSp) of RBT compared to culture as the gold standard were 87.5% and 100%, respectively, in studies that used suitable “true positive” and “true negative” patient comparison groups and were considered to be of high scientific quality. Diagnostic DSe and DSp of RBT compared to culture in studies that also used suitable “true positive” and “true negative” patient comparison groups but were considered to be of moderate scientific quality varied from 92.5% to 100% and 94.3 to 99.9%, respectively. The good diagnostic performance of RBT combined with its simplicity, quickness, and affordability makes RBT an ideal (or close to) stand-alone point-of-care test for early clinical diagnosis and management of human brucellosis and nonmalarial fevers in small and understaffed health facilities and laboratories in endemic areas in Africa and elsewhere.
机译:在特有的非洲地区,如坦桑尼亚,布鲁克拉SPP。导致人类发热性疾病,这往往未被识别和误诊,导致延迟诊断,下降,和低报。虽然可以在缺乏本地诊断性能数据的情况下,可用,接受和采用这些测试的快速且价格合理的护理点测试,例如玫瑰孟加拉峰试验(RBT),但在国家一级的情况下受到阻碍。为了解决这种需求,综述了关于RBT诊断性能作为人体布鲁氏菌病的诊断表现的证据。审查最初是专注于在坦桑尼亚进行的研究,但后来在全球范围内扩展,因为坦桑尼亚的少数有关的相关研究是被确定的。与参考标准培养相比,搜索了评估RBT(敏感性和特异性)诊断性能的研究,包括科学,Embase,Medline和世界卫生组织全球指标药物的数据库。在筛选后确定并审查了16项符合条件的研究。 RBT与培养相比,作为黄金标准的诊断敏感性(DSE)和特异性(DSP)分别为87.5%和100%,在使用合适的“真正阳性”和“真正的阴性”患者比较群体并被认为是科学质量很高。 RBT的诊断DSE和DSP与研究中的文化相比,也使用合适的“真正的阳性”和“真正的阴性”患者比较群体,但被认为是温和的科学品质,分别从92.5%到100%,分别为94.3%至99.9% 。 RBT的良好诊断性能结合其简单,QUICKENTY和可负担性,使RBT是一个理想的(或接近)独立的护理点测试,用于早期临床诊断和管理人体布鲁氏菌病和颈部腓骨卷积,较小,易于健康非洲和其他地方流行地区的设施和实验室。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号